British healthtech startup Maxwellia nabs €3.7 million to make medicines more accessible in pharmacies | EU-Startups
Summary
Maxwellia raised about €3.7 million in a funding round led by Praetura Ventures. The company converts prescription-only medicines into pharmacy-available products and is building a pipeline of over-the-counter switches. It already has multiple applications under review with the MHRA and expects its first women’s health product to move forward after public consultation. The company plans to use the capital to expand manufacturing, support the launch of its first product, invest in marketing, and grow the team.
Funding
Amount
$4.4M
Total raised
Date
April 8, 2021
Announcement date
Investors
Catapult Ventures, Future Fund, Alderley Park Ventures
Lead investors
Company
https://www.maxwellia.com/
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected